BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11555661)

  • 1. Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.
    English WR; Holtz B; Vogt G; Knäuper V; Murphy G
    J Biol Chem; 2001 Nov; 276(45):42018-26. PubMed ID: 11555661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.
    Butler GS; Butler MJ; Atkinson SJ; Will H; Tamura T; Schade van Westrum S; Crabbe T; Clements J; d'Ortho MP; Murphy G
    J Biol Chem; 1998 Jan; 273(2):871-80. PubMed ID: 9422744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A; Kolkenbrock H; Tschesche H
    FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H
    Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K; Lohi J; Valtanen H; Keski-Oja J
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
    Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H; Okada Y; Seiki M
    Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
    Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
    J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    Ann N Y Acad Sci; 1999 Jun; 878():710-2. PubMed ID: 10415815
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.
    Hernandez-Barrantes S; Toth M; Bernardo MM; Yurkova M; Gervasi DC; Raz Y; Sang QA; Fridman R
    J Biol Chem; 2000 Apr; 275(16):12080-9. PubMed ID: 10766841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
    EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
    Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
    J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.